Similar articles

• [Can observation be proposed in cases of clinically localized cancer of the prostate?].

  Martínez-Piñeiro JA. Martínez-Piñeiro JA. Arch Esp Urol. 1997 Dec;50(10):1033-6. Arch Esp Urol. 1997. PMID: 9494191 Spanish. No abstract available.
• Natural history of early, localized prostate cancer: a final report from three decades of follow-up.

  Popiolek M, Rider JR, Andrén O, Andersson SO, Holmberg L, Adami HO, Johansson JE. Popiolek M, et al. Eur Urol. 2013 Mar;63(3):428-35. doi: 10.1016/j.eururo.2012.10.002. Epub 2012 Oct 13. Eur Urol. 2013. PMID: 23084329
• Natural history of prostate cancer.

  Estebanez J, Teyrouz A, Gutierrez MA, Linazasoro I, Belloso J, Cano C, Peralta JM, Sanz JP. Estebanez J, et al. Arch Esp Urol. 2014 Jun;67(5):383-7. Arch Esp Urol. 2014. PMID: 24914836 Review. English, Spanish.
• Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.

  Debiais-Delpech C, Godet J, Pedretti N, Bernard FX, Irani J, Cathelineau X, Cussenot O, Fromont G. Debiais-Delpech C, et al. Urol Oncol. 2014 May;32(4):426-32. doi: 10.1016/j.urolonc.2013.09.006. Epub 2013 Dec 12. Urol Oncol. 2014. PMID: 24332637
• [Competitive morbidity ant its impact on life expectancy: evaluation and inclusion in the therapeutic decision regarding localized prostatic cancer].

  Soulié M, Villers A, Richaud P, Prapotnich D, Ruffion A, Grosclaude P. Soulié M, et al. Prog Urol. 2001 Dec;11(6):1195-204. Prog Urol. 2001. PMID: 11859652 Review. French.